Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia

Overview of attention for article published in Frontiers in Cell and Developmental Biology, August 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 11,896 followers.

RT @CARTTherapy: Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia https://t.co/31DcCt0IS0…

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia https://t.co/31DcCt0IS0 #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy @ASTCT

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia - PubMed https://t.co/hF52NzRIds

Chimeric Antigen Receptor T Cells Targeting Cell Surface GRP78 to Eradicate Acute Myeloid Leukemia #lymphoma #lymsm https://t.co/xbHWep0mAU

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.